Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 3 |
2019 | 1 |
2020 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
madsen mark
(59 results)?
Platelet activation parameters and platelet-leucocyte-conjugate formation in glioblastoma multiforme patients.
Oncotarget. 2018 May 25;9(40):25860-25876. doi: 10.18632/oncotarget.25395. eCollection 2018 May 25.
Oncotarget. 2018.
PMID: 29899827
Free PMC article.
Reduction of CD11b+ myeloid suppressive cells augments anti-neuroblastoma immune response induced by the anti-GD2 antibody ch14.18/CHO.
Siebert N, Zumpe M, von Lojewski L, Troschke-Meurer S, Marx M, Lode HN.
Siebert N, et al. Among authors: marx m.
Oncoimmunology. 2020 Oct 24;9(1):1836768. doi: 10.1080/2162402X.2020.1836768.
Oncoimmunology. 2020.
PMID: 33150046
Free PMC article.
Item in Clipboard
Co-expression of IL-15 enhances anti-neuroblastoma effectivity of a tyrosine hydroxylase-directed DNA vaccination in mice.
Marx M, Zumpe M, Troschke-Meurer S, Shah D, Lode HN, Siebert N.
Marx M, et al.
PLoS One. 2018 Nov 19;13(11):e0207320. doi: 10.1371/journal.pone.0207320. eCollection 2018.
PLoS One. 2018.
PMID: 30452438
Free PMC article.
Item in Clipboard
GD2 targeting by dinutuximab beta is a promising immunotherapeutic approach against malignant glioma.
Marx S, Wilken F, Wagner I, Marx M, Troschke-Meurer S, Zumpe M, Bien-Moeller S, Weidemeier M, Baldauf J, Fleck SK, Rauch BH, Schroeder HWS, Lode H, Siebert N.
Marx S, et al. Among authors: marx m.
J Neurooncol. 2020 May;147(3):577-585. doi: 10.1007/s11060-020-03470-3. Epub 2020 Apr 3.
J Neurooncol. 2020.
PMID: 32246395
Item in Clipboard
Low CD4⁺/CD25⁺/CD127⁻ regulatory T cell- and high INF-γ levels are associated with improved survival of neuroblastoma patients treated with long-term infusion of ch14.18/CHO combined with interleukin-2.
Troschke-Meurer S, Siebert N, Marx M, Zumpe M, Ehlert K, Mutschlechner O, Loibner H, Ladenstein R, Lode HN.
Troschke-Meurer S, et al. Among authors: marx m.
Oncoimmunology. 2019 Sep 8;8(12):1661194. doi: 10.1080/2162402X.2019.1661194. eCollection 2019.
Oncoimmunology. 2019.
PMID: 31741754
Free PMC article.
Item in Clipboard
Impact of HACA on Immunomodulation and Treatment Toxicity Following ch14.18/CHO Long-Term Infusion with Interleukin-2: Results from a SIOPEN Phase 2 Trial.
Siebert N, Troschke-Meurer S, Marx M, Zumpe M, Ehlert K, Gray J, Garaventa A, Manzitti C, Ash S, Klingebiel T, Beck J, Castel V, Valteau-Couanet D, Loibner H, Ladenstein R, Lode HN.
Siebert N, et al. Among authors: marx m.
Cancers (Basel). 2018 Oct 17;10(10):387. doi: 10.3390/cancers10100387.
Cancers (Basel). 2018.
PMID: 30336605
Free PMC article.
Item in Clipboard
Cite
Cite